Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Emerging Markets Health Care -- A Unique Challenge

Our health care roundtable gathers the Motley Fool's top health care analysts to discuss the sector's biggest stories in a free flowing and highly opinionated format.

In this portion of the video, the guys discuss one of Johnson & Johnson's (NYSE: JNJ  ) major acquisitions in the medical devices space and whether it was a good idea considering that the company has seen some slowdown in that area. They discuss the huge potential with rapidly growing emerging markets and the difficulty in tapping those markets when the people there simply don't have as much money to spend.

In the world of health care, companies simply don't come any bigger than Johnson & Johnson. Many own the stock, but few understand its story. Offering everything from baby powder to biologics, critics think the company has spread itself too thin, becoming nothing more than a bloated corporate whale. Is this true, or is J&J a well-diversified giant that's perfect for your portfolio? Make sure you understand the full story behind the stock, along with its key opportunities and risks, by checking out our brand new premium report on Johnson & Johnson. To claim your copy simply click here now for instant access.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2161749, ~/Articles/ArticleHandler.aspx, 10/24/2016 12:39:16 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,226.01 80.30 0.44%
S&P 500 2,148.89 7.73 0.36%
NASD 5,300.91 43.51 0.83%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 12:23 PM
JNJ $113.88 Up +0.44 +0.39%
Johnson and Johnso… CAPS Rating: ****
ABT $40.57 Up +0.07 +0.16%
Abbott Laboratorie… CAPS Rating: *****
MDT $83.70 Down -0.21 -0.25%
Medtronic CAPS Rating: *****
NVS $75.19 Down -0.35 -0.46%
Novartis CAPS Rating: ****